NIPH Clinical Trials Search

UMIN ID: UMIN000010377

Registered date:15/04/2013

Therapeutic effect of jizusoippo for symptoms of Yusho patients exposed to dioxins

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedYusho disease
Date of first enrollment2013/01/01
Target sample size50
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Patients take 2.5g of Jizusoippo three times a day after each meal for 6months.


Primary Outcomerespiratory, skin, and neurological symptoms, general fatigue, and QOL
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaPatients are not eligible if they have serious diseases (malignant neoplasms, hepatic disorders, renal disorders, or blood disorders), have been treated with any other Kampo formulae, or are women with pregnancy or nursing women. Patients who are judged to have an ineligible health condition by medical doctors are excluded.

Related Information


public contact
Name Hiroshi Uchi
Address 3-1-1, Maidashi, Higashiku, Fukuoka Japan
Telephone 092-642-5211
Affiliation Kyushu University Hospital Research and Clinical Center for Yusho
scientific contact
Name Masutaka Furue
Address 3-1-1, Maidashi, Higashiku, Fukuoka Japan
Affiliation Kyushu University Hospital Dermatology